Connected expertise is reshaping infectious disease research in Europe

This article is in partnership with:

Lennie Derde

CEO, Ecraid

Professor Evelina Tacconelli

Chief Scientific Officer, Ecraid

A European network of expertise and clinical infrastructure is helping deliver high-quality, coordinated and impactful research to tackle the burden of infectious disease.


European infectious disease research is fragmented, often requiring new clinical studies to rebuild infrastructure and procedures. This inefficient use of resources delays study findings and slows patient access to therapies for antimicrobial-resistant infections.

Uniting fragmented infectious disease research

Access to clinical research infrastructure and opportunities to participate in multinational studies remains uneven across Europe. The not-for-profit foundation Ecraid (European Clinical Research Alliance on Infectious Diseases) aims to harmonise Europe’s disparate infectious disease research systems by ensuring the right expertise is in the right place and connected at scale.

We provide our partners in academia and industry with a single point of access
to a network of expertise and continuously functioning clinical infrastructure

Ecraid has been building an ecosystem of research sites across Europe (with over 1,250 hospitals, 250 GPs and key opinion leaders) so that high-quality data, resources and expertise can be shared across borders easily. Additionally, it’s actively shaping clinical trials with innovative adaptive platform trial designs that can rapidly pivot in response to emerging health threats.

A single point of access to a network of expertise

“We provide our partners in academia and industry with a single point of access to a network of expertise and continuously functioning clinical infrastructure,” explains Lennie Derde, CEO. “This enables a coordinated and efficient delivery of the observational and interventional studies needed in the fields of infectious disease, including AMR and other emerging health threats.”

Professor Evelina Tacconelli, CSO, says: “Results from our studies have been included in guidelines that impact how infectious disease patients are treated and managed across Europe. This requires rigorous study design and participation across diverse healthcare settings. We also provide training and methodological support to help participating teams strengthen their capacity to contribute to high-quality multinational research.” Through its integrated ecosystem, Ecraid helps organisations generate robust evidence and translate research into impact for patients, healthcare systems and society.

More from AMR & Infectious Diseases